Difference between revisions of "OMP ST:1214 ! Escherichia coli K-12 JW0451"
Kylliechang (talk | contribs) (Table edited by Kylliechang via TableEdit) |
(touch) |
||
(36 intermediate revisions by 3 users not shown) | |||
Line 6: | Line 6: | ||
****************************************************************************************** | ****************************************************************************************** | ||
* | * | ||
− | + | ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | |
* | * | ||
****************************************************************************************** --> | ****************************************************************************************** --> | ||
Line 50: | Line 50: | ||
|<div class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.8916.R57d6f93f32107&page=8916&pagename={{FULLPAGENAMEE}}&type=1&template=Strain_info_table edit table]</div> || | |<div class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.8916.R57d6f93f32107&page=8916&pagename={{FULLPAGENAMEE}}&type=1&template=Strain_info_table edit table]</div> || | ||
|} | |} | ||
− | |||
− | |||
− | |||
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.8916.R57d6f93f32107--></protect> | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.8916.R57d6f93f32107--></protect> | ||
Line 64: | Line 61: | ||
****************************************************************************************** | ****************************************************************************************** | ||
* | * | ||
− | + | ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | |
* | * | ||
****************************************************************************************** --> | ****************************************************************************************** --> | ||
{| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; border: 1px #aaa solid; border-collapse: collapse;" id="Z57d6f93f35485" class=" tableEdit OMP_annotation_table dataTable" | {| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; border: 1px #aaa solid; border-collapse: collapse;" id="Z57d6f93f35485" class=" tableEdit OMP_annotation_table dataTable" | ||
|- align='left' bgcolor='#CCCCFF' | |- align='left' bgcolor='#CCCCFF' | ||
− | !|Annotation ID!! | + | !|Annotation ID!!Qualifier!!OMP ID!!OMP term name!!Relative phenotype information!!Experimental condition!!ECO ID!!ECO term name!!Reference!!Annotation Extension!!Notes |
|- | |- | ||
| | | | ||
Line 76: | Line 73: | ||
| | | | ||
− | + | OMP:0005347 | |
| | | | ||
Line 83: | Line 80: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 111: | Line 108: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 139: | Line 136: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 167: | Line 164: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 195: | Line 192: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 223: | Line 220: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 251: | Line 248: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 279: | Line 276: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 307: | Line 304: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 335: | Line 332: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 363: | Line 360: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 391: | Line 388: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 419: | Line 416: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 447: | Line 444: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 475: | Line 472: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 503: | Line 500: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 531: | Line 528: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 559: | Line 556: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 587: | Line 584: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 615: | Line 612: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 643: | Line 640: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 671: | Line 668: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 699: | Line 696: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 709: | Line 706: | ||
| | | | ||
− | + | PMID:21185072 | |
| | | | ||
CHEBI:17939 puromycin | CHEBI:17939 puromycin | ||
Line 728: | Line 725: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 756: | Line 753: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 784: | Line 781: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 812: | Line 809: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 840: | Line 837: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 865: | Line 862: | ||
decreased resistance to tetracycline | decreased resistance to tetracycline | ||
| | | | ||
− | Relative to: OMP_AN: | + | Relative to: OMP_AN:870 |
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
| | | | ||
− | medium:doxycycline (0 | + | medium:doxycycline (1.0 ug ml-1) |
| | | | ||
Line 882: | Line 879: | ||
CHEBI:50845 doxycycline | CHEBI:50845 doxycycline | ||
| | | | ||
− | fitness score = - | + | fitness score = -9.99 |
|- | |- | ||
| | | | ||
Line 896: | Line 893: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 924: | Line 921: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 952: | Line 949: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 980: | Line 977: | ||
<hr>Genotype differences:<br> | <hr>Genotype differences:<br> | ||
− | +acrB747(del) | + | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) |
<hr>Condition differences:<br> | <hr>Condition differences:<br> | ||
no differences | no differences | ||
Line 995: | Line 992: | ||
| | | | ||
fitness score = -3.30 | fitness score = -3.30 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1328 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007250 | ||
+ | | | ||
+ | decreased sensitivity to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:851 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:cholate 2.0% | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:29747 cholate | ||
+ | | | ||
+ | fitness score = -15.87 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1332 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0005276 | ||
+ | | | ||
+ | decreased resistance to organic heterocyclic compound | ||
+ | | | ||
+ | Relative to: OMP_AN:1331 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:nalidixic acid (2.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:100147 nalidixic acid | ||
+ | | | ||
+ | fitness score = -12.17 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1333 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006044 | ||
+ | | | ||
+ | decreased resistance to beta-lactam | ||
+ | | | ||
+ | Relative to: OMP_AN:661 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:mecillinam (0.09 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:51208 mecillinam | ||
+ | | | ||
+ | fitness score = -10.45 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1335 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006044 | ||
+ | | | ||
+ | decreased resistance to beta-lactam | ||
+ | | | ||
+ | Relative to: OMP_AN:1334 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:ampicillin (8.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:28971 ampicillin | ||
+ | | | ||
+ | fitness score = -10.32 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1336 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007250 | ||
+ | | | ||
+ | decreased sensitivity to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:861 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:bile 2.0% | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:22868 bile | ||
+ | | | ||
+ | fitness score = -12.10 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1338 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0005276 | ||
+ | | | ||
+ | decreased resistance to organic heterocyclic compound | ||
+ | | | ||
+ | Relative to: OMP_AN:1337 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:pyocyanin (10.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:62220 pyocyanin | ||
+ | | | ||
+ | fitness score = -11.92 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1340 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006061 | ||
+ | | | ||
+ | decreased resistance to tetracycline | ||
+ | | | ||
+ | Relative to: OMP_AN:1339 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:tetracycline (0.75 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:35006 tetracycline hydrochloride | ||
+ | | | ||
+ | fitness score = -8.81 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1341 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007250 | ||
+ | | | ||
+ | decreased sensitivity to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:847 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:SDS 4.0% | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:8984 SDS | ||
+ | | | ||
+ | fitness score = -8.31 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1343 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006040 | ||
+ | | | ||
+ | decreased resistance to quinolone | ||
+ | | | ||
+ | Relative to: OMP_AN:1342 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:ciprofloxacin (0.006 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:100241 ciprofloxacin | ||
+ | | | ||
+ | fitness score = -3.43 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1345 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0005276 | ||
+ | | | ||
+ | decreased resistance to organic heterocyclic compound | ||
+ | | | ||
+ | Relative to: OMP_AN:1344 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:spectinomycin (4.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:9215 spectinomycin | ||
+ | | | ||
+ | fitness score = -7.66 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1347 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007173 | ||
+ | | | ||
+ | decreased resistance to antimicrobial peptide | ||
+ | | | ||
+ | Relative to: OMP_AN:1346 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:bleomycin (1.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:22907 bleomycin | ||
+ | | | ||
+ | fitness score = -3.66 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1348 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006036 | ||
+ | | | ||
+ | decreased resistance to macrolide | ||
+ | | | ||
+ | Relative to: OMP_AN:681 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:azithromycin (1.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:2955 azithromycin | ||
+ | |||
+ | | | ||
+ | fitness score = -6.36 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1349 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007250 | ||
+ | | | ||
+ | decreased sensitivity to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:857 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:taurocholate 1.0% | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:36257 taurocholate | ||
+ | | | ||
+ | fitness score = -5.94 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1351 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007363 | ||
+ | | | ||
+ | decreased resistance to a nucleoside | ||
+ | | | ||
+ | Relative to: OMP_AN:1350 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:azidothymidine (2.5 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:10110 azidothymidine | ||
+ | | | ||
+ | fitness score = -4.31 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1352 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0005276 | ||
+ | | | ||
+ | decreased resistance to organic heterocyclic compound | ||
+ | | | ||
+ | Relative to: OMP_AN:885 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:chloropromazine (24 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:3647 chloropromazine | ||
+ | | | ||
+ | fitness score = -4.22 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1391 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007250 | ||
+ | | | ||
+ | decreased sensitivity to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:1390 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:peroxide (1.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:44785 peroxide | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | | | ||
+ | fitness score = 3.17 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1392 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007377 | ||
+ | | | ||
+ | decreased resistance to alkylating agent | ||
+ | | | ||
+ | Relative to: OMP_AN:685 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:MMS (0.05%) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:25255 MMS | ||
+ | | | ||
+ | fitness score = 3.18 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:1395 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007500 | ||
+ | | | ||
+ | decreased resistance to an epoxide | ||
+ | | | ||
+ | Relative to: OMP_AN:1393 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | medium:cerulenin (6.0 ug ml-1) | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | CHEBI:171741 cerulenin | ||
+ | | | ||
+ | fitness score = -12.35 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28508 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006045 | ||
+ | | | ||
+ | increased resistance to beta-lactam compound | ||
+ | | | ||
+ | Relative to: OMP_AN:27530 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Amoxicillin | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:2676) Amoxicillin | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 1.5 ug/ml | ||
+ | *normalized fitness= 3.56 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28509 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006044 | ||
+ | | | ||
+ | decreased resistance to beta-lactam | ||
+ | | | ||
+ | Relative to: OMP_AN:27531 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Ampicillin | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:28971) Ampicillin | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 8 ug/ml | ||
+ | *normalized fitness= -10.32 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28510 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007879 | ||
+ | | | ||
+ | decreased resistance to an antimicrobial agent | ||
+ | | | ||
+ | Relative to: OMP_AN:27552 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Azidothymidine | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:10110) Azidothymidine | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 2.5 ng/ml | ||
+ | *normalized fitness= -4.31 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28511 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0006036 | ||
+ | | | ||
+ | decreased resistance to macrolide | ||
+ | | | ||
+ | Relative to: OMP_AN:27518 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Azithromycin | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:2955) Azithromycin | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 1 ug/ml | ||
+ | *normalized fitness= -6.36 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28512 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007249 | ||
+ | | | ||
+ | decreased resistance to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:27514 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Chlorpromazine hydrochloride | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:3649) Chlorpromazine hydrochloride | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 6 uM | ||
+ | *normalized fitness= -4.22 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28513 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007902 | ||
+ | | | ||
+ | increased resistance to bile acids | ||
+ | | | ||
+ | Relative to: OMP_AN:27585 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Cholate sodium hydrate | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CID:23679061) Cholate sodium hydrate | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 0.1 % | ||
+ | *normalized fitness= 3.67 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28514 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007879 | ||
+ | | | ||
+ | decreased resistance to an antimicrobial agent | ||
+ | | | ||
+ | Relative to: OMP_AN:27506 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Doxorubicin hydrochloride | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:31522) Doxorubicin hydrochloride | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 10 ug/ml | ||
+ | *normalized fitness= -17.37 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28515 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007249 | ||
+ | | | ||
+ | decreased resistance to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:27510 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Mitomycin C | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:27504) Mitomycin C | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 0.1 ug/ml | ||
+ | *normalized fitness= -24.34 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28516 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007903 | ||
+ | | | ||
+ | decreased resistance to bile acids | ||
+ | | | ||
+ | Relative to: OMP_AN:27584 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Taurocholic acid sodium salt hydrate | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CID:23687511) Taurocholic acid sodium salt hydrate | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 1 % | ||
+ | *normalized fitness= -5.94 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28517 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007879 | ||
+ | | | ||
+ | decreased resistance to an antimicrobial agent | ||
+ | | | ||
+ | Relative to: OMP_AN:27588 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Triclosan/Irgasan | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:164200) Triclosan/Irgasan | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 0.05 ug/ml | ||
+ | *normalized fitness= -14.74 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28518 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007878 | ||
+ | | | ||
+ | increased resistance to an antimicrobial agent | ||
+ | | | ||
+ | Relative to: OMP_AN:27566 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:Vancomycin HCl hydrate | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:9932) Vancomycin HCl hydrate | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 10 ug/ml | ||
+ | *normalized fitness= 3.8 | ||
+ | |- | ||
+ | | | ||
+ | OMP_AN:28519 | ||
+ | | | ||
+ | |||
+ | | | ||
+ | OMP:0007250 | ||
+ | | | ||
+ | increased resistance to a chemical | ||
+ | | | ||
+ | Relative to: OMP_AN:27569 | ||
+ | |||
+ | <hr>Genotype differences:<br> | ||
+ | +lacZ4787(del)( +acrB747(del) -lacZ4787(del) | ||
+ | <hr>Condition differences:<br> | ||
+ | no differences | ||
+ | | | ||
+ | |||
+ | *temperature:37C | ||
+ | *medium:LB agar | ||
+ | *medium:EtOH | ||
+ | | | ||
+ | ECO:0007005 | ||
+ | | | ||
+ | high throughput direct assay evidence used in manual assertion | ||
+ | | | ||
+ | PMID:21185072 | ||
+ | | | ||
+ | towards some (CHEBI:16236) EtOH | ||
+ | | | ||
+ | |||
+ | *chemical concentration= 6 % | ||
+ | *normalized fitness= 3.05 | ||
|- class="tableEdit_footer" | |- class="tableEdit_footer" | ||
|<div class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.8916.Z57d6f93f35485&page=8916&pagename={{FULLPAGENAMEE}}&type=0&template=OMP_annotation_table edit table]</div> || || || || || || || || || || | |<div class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.8916.Z57d6f93f35485&page=8916&pagename={{FULLPAGENAMEE}}&type=0&template=OMP_annotation_table edit table]</div> || || || || || || || || || || | ||
|} | |} | ||
− | |||
− | |||
− | |||
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.8916.Z57d6f93f35485--></protect> | <!--box uid=d41d8cd98f00b204e9800998ecf8427e.8916.Z57d6f93f35485--></protect> | ||
Latest revision as of 20:51, 22 October 2019
Contents
Strain Summary
Strain Name |
Escherichia coli K-12 JW0451 |
---|---|
Synonyms |
BW25113 acrB747(del)::kan, ECK0456 |
Taxon Information |
|
Genotype |
DE(araD-araB)567 DE(rhaD-rhaB)568 F- Lambda- hsdR514 lacZ4787(del)(::rrnB-3) rph-1 acrB747(del)::kan |
Strain Reference |
|
Strain availability | |
Ancestry | |
Annotated phenotypes |
|
Notes
Phenotype Annotation
Annotation ID | Qualifier | OMP ID | OMP term name | Relative phenotype information | Experimental condition | ECO ID | ECO term name | Reference | Annotation Extension | Notes |
---|---|---|---|---|---|---|---|---|---|---|
OMP_AN:1098 |
OMP:0005347 |
Relative to: OMP_AN:817 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:procaine (30 ug ml-1) |
CHEBI:8430 procaine |
fitness score = 7.16 | |||||
OMP_AN:1100 |
OMP:0007249 |
Increased sensitivity to a chemical |
Relative to: OMP_AN:1099 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:EGTA (2.0 ug ml-1) |
CHEBI:30740 EGTA |
fitness score = 3.83 | ||||
OMP_AN:1102 |
OMP:0007249 |
Increased sensitivity to a chemical |
Relative to: OMP_AN:1101 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:polymixin B (6.0 ug ml-1) |
CHEBI:8309 polymixin B |
fitness score = 4.02 | ||||
OMP_AN:1104 |
OMP:0007174 |
increased resistance to antimicrobial peptide |
Relative to: OMP_AN:1103 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:vancomycin (10 ug ml-1) |
CHEBI:28001 vancomycin |
fitness score = 3.80 | ||||
OMP_AN:1105 |
OMP:0006041 |
increased resistance to quinolone |
Relative to: OMP_AN:703 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:doxorubicin (1.0 ug ml-1) |
CHEBI:28748 doxorubicin |
fitness score = 3.70 | ||||
OMP_AN:1107 |
OMP:0007249 |
Increased sensitivity to a chemical |
Relative to: OMP_AN:1106 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:cholate 0.1% |
CHEBI:29747 cholate |
fitness score = 3.67 | ||||
OMP_AN:1109 |
OMP:0006045 |
increased resistance to beta-lactam compound |
Relative to: OMP_AN:1108 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:amoxicillin (1.5 ug ml-1) |
CHEBI:2676 amoxicillin |
itness score = 3.56 | ||||
OMP_AN:1111 |
OMP:0006045 |
increased resistance to beta-lactam compound |
Relative to: OMP_AN:1110 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:ampicillin (2.0 ug ml-1) |
CHEBI:28971 ampicillin |
fitness score = 3.28 | ||||
OMP_AN:1113 |
OMP:0006045 |
increased resistance to beta-lactam compound |
Relative to: OMP_AN:1112 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:aztreonam (0.002 ug ml-1) |
CHEBI:161680 aztreonam |
fitness score = 3.16 | ||||
OMP_AN:1115 |
OMP:0005097 |
increased resistance to UV radiation |
Relative to: OMP_AN:1114 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:UV (24 seconds) |
fitness score = 3.20 | |||||
OMP_AN:1117 |
OMP:0007249 |
Increased sensitivity to a chemical |
Relative to: OMP_AN:1116 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:ethanol (6.0 ug ml-1) |
CHEBI:16236 ethanol |
fitness score = 3.05 | ||||
OMP_AN:1130 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:841 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:dibucaine (1.2 ug ml-1) |
CHEBI:247956 dibucaine |
fitness score = -26.92 | ||||
OMP_AN:1162 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:689 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:propidium iodide (50 ug ml-1) |
CHEBI:51240 propidium iodide |
fitness score = -23.56 | ||||
OMP_AN:1163 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:822 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:novobiocin (30 ug ml-1) |
CHEBI:28368 novobiocin |
fitness score = -26.29 | ||||
OMP_AN:1164 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:849 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:oxacillin (40 ug ml-1) |
CHEBI:7809 oxacillin |
fitness score = -25.93 | ||||
OMP_AN:1165 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:855 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:mitomycinc (0.1 ug ml-1) |
CHEBI:27504 mitomycinc |
fitness score = -24.34 | ||||
OMP_AN:1166 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:835 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:ethidium bromide (50 ug ml-1) |
CHEBI:4883 ethidium bromide |
fitness score = -22.13 | ||||
OMP_AN:1167 |
OMP:0006067 |
decreased resistance to chloramphenicol |
Relative to: OMP_AN:649 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:chloramphenicol (2.0 ug ml-1) |
CHEBI:17698 chloramphenicol |
fitness score = -16.67 | ||||
OMP_AN:1168 |
OMP:0007385 |
decreased resistance benzamides |
Relative to: OMP_AN:659 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:CHIR-090 (0.075 ug ml-1) |
PubChem CID:11546620 Chir-090 |
fitness score = -10.62 | ||||
OMP_AN:1169 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:872 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:erythromycin (10.0 ug ml-1) |
CHEBI:48923 erythromycin |
fitness score = -20.89 | ||||
OMP_AN:1170 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:845 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:deoxycholate 2.0% |
CHEBI:23614 deoxycholate |
fitness score = -20.88 | ||||
OMP_AN:1171 |
OMP:0000335 |
decreased resistance to aminopyrimidine |
Relative to: OMP_AN:853 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:trimethoprim (0.4 ug ml-1) |
CHEBI:45924 trimethoprim |
fitness score = -11.04 | ||||
OMP_AN:1172 |
OMP:0007363 |
decreased resistance to a nucleoside |
Relative to: OMP_AN:657 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:puromycin (25 ug ml-1) |
CHEBI:17939 puromycin |
fitness score = -20.05 | ||||
OMP_AN:1173 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:868 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:fusidic acid (50 ug ml-1) |
CHEBI:29013 fusidicacid |
fitness score = -18.70 | ||||
OMP_AN:1174 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:859 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:clarythromycin (10.0 ug ml-1) |
CID: 84029 clarythromycin |
fitness score = -19.37 | ||||
OMP_AN:1230 |
OMP:0006061 |
decreased resistance to tetracycline |
Relative to: OMP_AN:668 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:minocycline (1.0 ug ml-1) |
CHEBI:50694 minocycline |
fitness score = -13.86 | ||||
OMP_AN:1231 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:863 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:spiramycin (20 ug ml-1) |
CHEBI:85260 spiramycin |
fitness score = -18.68 | ||||
OMP_AN:1232 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:843 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:doxorubicin (10 ug ml-1) |
CHEBI:28748 doxorubicin |
fitness score = -17.37 | ||||
OMP_AN:1234 |
OMP:0006061 |
decreased resistance to tetracycline |
Relative to: OMP_AN:870 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:doxycycline (1.0 ug ml-1) |
CHEBI:50845 doxycycline |
fitness score = -9.99 | ||||
OMP_AN:1323 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:653 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:streptonigrin (0.5 ug ml-1) |
CHEBI:9287 streptonigrin |
fitness score = -16.75 | ||||
OMP_AN:1325 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:1324 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:PMS (0.1 ug ml-1) |
CHEBI:53396 PMS |
fitness score = -15.93 | ||||
OMP_AN:1326 |
OMP:0007370 |
decreased resistance to an acridine |
Relative to: OMP_AN:663 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:acriflavine (10 ug ml-1) |
CHEBI:74728 acriflavinium chloride |
fitness score = -16.66 | ||||
OMP_AN:1327 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:894 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:verapamil (1.0 ug ml-1) |
CHEBI:9948 verapamil |
fitness score = -3.30 | ||||
OMP_AN:1328 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:851 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:cholate 2.0% |
CHEBI:29747 cholate |
fitness score = -15.87 | ||||
OMP_AN:1332 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:1331 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:nalidixic acid (2.0 ug ml-1) |
CHEBI:100147 nalidixic acid |
fitness score = -12.17 | ||||
OMP_AN:1333 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:661 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:mecillinam (0.09 ug ml-1) |
CHEBI:51208 mecillinam |
fitness score = -10.45 | ||||
OMP_AN:1335 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:1334 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:ampicillin (8.0 ug ml-1) |
CHEBI:28971 ampicillin |
fitness score = -10.32 | ||||
OMP_AN:1336 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:861 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:bile 2.0% |
CHEBI:22868 bile |
fitness score = -12.10 | ||||
OMP_AN:1338 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:1337 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:pyocyanin (10.0 ug ml-1) |
CHEBI:62220 pyocyanin |
fitness score = -11.92 | ||||
OMP_AN:1340 |
OMP:0006061 |
decreased resistance to tetracycline |
Relative to: OMP_AN:1339 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:tetracycline (0.75 ug ml-1) |
CHEBI:35006 tetracycline hydrochloride |
fitness score = -8.81 | ||||
OMP_AN:1341 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:847 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:SDS 4.0% |
CHEBI:8984 SDS |
fitness score = -8.31 | ||||
OMP_AN:1343 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:1342 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:ciprofloxacin (0.006 ug ml-1) |
CHEBI:100241 ciprofloxacin |
fitness score = -3.43 | ||||
OMP_AN:1345 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:1344 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:spectinomycin (4.0 ug ml-1) |
CHEBI:9215 spectinomycin |
fitness score = -7.66 | ||||
OMP_AN:1347 |
OMP:0007173 |
decreased resistance to antimicrobial peptide |
Relative to: OMP_AN:1346 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:bleomycin (1.0 ug ml-1) |
CHEBI:22907 bleomycin |
fitness score = -3.66 | ||||
OMP_AN:1348 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:681 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:azithromycin (1.0 ug ml-1) |
CHEBI:2955 azithromycin |
fitness score = -6.36 | ||||
OMP_AN:1349 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:857 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:taurocholate 1.0% |
CHEBI:36257 taurocholate |
fitness score = -5.94 | ||||
OMP_AN:1351 |
OMP:0007363 |
decreased resistance to a nucleoside |
Relative to: OMP_AN:1350 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:azidothymidine (2.5 ug ml-1) |
CHEBI:10110 azidothymidine |
fitness score = -4.31 | ||||
OMP_AN:1352 |
OMP:0005276 |
decreased resistance to organic heterocyclic compound |
Relative to: OMP_AN:885 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:chloropromazine (24 ug ml-1) |
CHEBI:3647 chloropromazine |
fitness score = -4.22 | ||||
OMP_AN:1391 |
OMP:0007250 |
decreased sensitivity to a chemical |
Relative to: OMP_AN:1390 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:peroxide (1.0 ug ml-1) |
CHEBI:44785 peroxide
|
fitness score = 3.17 | ||||
OMP_AN:1392 |
OMP:0007377 |
decreased resistance to alkylating agent |
Relative to: OMP_AN:685 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:MMS (0.05%) |
CHEBI:25255 MMS |
fitness score = 3.18 | ||||
OMP_AN:1395 |
OMP:0007500 |
decreased resistance to an epoxide |
Relative to: OMP_AN:1393 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
medium:cerulenin (6.0 ug ml-1) |
CHEBI:171741 cerulenin |
fitness score = -12.35 | ||||
OMP_AN:28508 |
OMP:0006045 |
increased resistance to beta-lactam compound |
Relative to: OMP_AN:27530 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:2676) Amoxicillin |
| ||
OMP_AN:28509 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27531 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:28971) Ampicillin |
| ||
OMP_AN:28510 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27552 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:10110) Azidothymidine |
| ||
OMP_AN:28511 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27518 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:2955) Azithromycin |
| ||
OMP_AN:28512 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27514 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:3649) Chlorpromazine hydrochloride |
| ||
OMP_AN:28513 |
OMP:0007902 |
increased resistance to bile acids |
Relative to: OMP_AN:27585 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:23679061) Cholate sodium hydrate |
| ||
OMP_AN:28514 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27506 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:31522) Doxorubicin hydrochloride |
| ||
OMP_AN:28515 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27510 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:27504) Mitomycin C |
| ||
OMP_AN:28516 |
OMP:0007903 |
decreased resistance to bile acids |
Relative to: OMP_AN:27584 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:23687511) Taurocholic acid sodium salt hydrate |
| ||
OMP_AN:28517 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27588 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:164200) Triclosan/Irgasan |
| ||
OMP_AN:28518 |
OMP:0007878 |
increased resistance to an antimicrobial agent |
Relative to: OMP_AN:27566 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:9932) Vancomycin HCl hydrate |
| ||
OMP_AN:28519 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27569 Genotype differences: +lacZ4787(del)( +acrB747(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:16236) EtOH |
| ||
Additional Information
Links
References
See Help:References for how to manage references in OMPwiki.
- ↑ Baba, T et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2 2006.0008 PubMed OMPwiki page
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 2.34 2.35 2.36 2.37 2.38 2.39 2.40 2.41 2.42 2.43 2.44 2.45 2.46 2.47 2.48 2.49 2.50 2.51 2.52 2.53 2.54 2.55 2.56 2.57 2.58 2.59 2.60 2.61 2.62 Nichols, RJ et al. (2011) Phenotypic landscape of a bacterial cell. Cell 144 143-56 PubMed OMPwiki page
o
- OMP:0000335 ! decreased resistance to aminopyrimidine
- OMP:0005097 ! increased resistance to UV radiation
- OMP:0005276 ! decreased resistance to organic heterocyclic compound
- OMP:0005347 ! increased resistance to organic aromatic compounds
- OMP:0006036 ! decreased resistance to macrolide
- OMP:0006040 ! decreased resistance to quinolone
- OMP:0006041 ! increased resistance to quinolone
- OMP:0006044 ! decreased resistance to beta-lactam
- OMP:0006045 ! increased resistance to beta-lactam compound
- OMP:0006061 ! decreased resistance to tetracycline
- OMP:0006067 ! decreased resistance to chloramphenicol
- OMP:0007173 ! decreased resistance to antimicrobial peptide
- OMP:0007174 ! increased resistance to antimicrobial peptide
- OMP:0007249 ! decreased resistance to a chemical
- OMP:0007250 ! increased resistance to a chemical
- OMP:0007363 ! decreased resistance to a nucleoside
- OMP:0007370 ! decreased resistance to an acridine
- OMP:0007377 ! decreased resistance to alkylating agent
- OMP:0007385 ! decreased resistance benzamides
- OMP:0007500 ! decreased resistance to an epoxide
- OMP:0007878 ! increased resistance to an antimicrobial agent
- OMP:0007879 ! decreased resistance to an antimicrobial agent
- OMP:0007902 ! increased resistance to bile acids
- OMP:0007903 ! decreased resistance to bile acids